Atria Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-460
Closed -$20K 1097
2019
Q1
$20K Sell
460
-39
-8% -$1.7K ﹤0.01% 916
2018
Q4
$7K Buy
+499
New +$7K ﹤0.01% 874